Henkel's Sales Slightly Beat Expectations
By Mauro Orru
Henkel posted sales slightly ahead of analysts' forecasts for last year.
The German chemical and consumer-goods company on Monday reported sales of 21.51 billion euros ($23.32 billion) for 2023, down 3.9% in reported terms but up 4.2% organically from the previous year.
The company's adjusted return on sales increased to 11.9% from 10.4% in 2022. Adjusted earnings per preferred share--a closely watched profitability metric--grew 20% at constant exchange rates to EUR4.35.
Henkel said it would propose a 2023 dividend of EUR1.85 per preferred share and EUR1.83 per ordinary share to its annual general meeting on April 22, the same it paid for the previous year.
The group was expected to post annual sales of EUR21.50 billion, an adjusted return on sales of 12% and adjusted earnings per preferred share of EUR4.35, according to a Vara Research consensus based on estimates from 18 analysts.
This year, the group is forecasting organic sales growth of 2% to 4%, an adjusted return on sales between 12% and 13.5% and adjusted earnings per preferred share up 5% to 20% at constant exchange rates.
Write to Mauro Orru at mauro.orru@wsj.com
(END) Dow Jones Newswires
March 04, 2024 02:01 ET (07:01 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks